News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kamdar Kim P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Sold 353,657 shares
@ $0.5955, valued at
$210.6k
Sold 77,991 shares
@ $0.5696, valued at
$44.4k
Sold 200,000 shares
@ $0.5348, valued at
$107k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Granted 63,265 options to buy
@ $3, valued at
$189.8k
|
|
| 05/26/2023 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 74,000 options to buy
@ $1.06, valued at
$78.4k
|
|
| 06/06/2022 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Granted 149,675 options to buy
@ $1.35, valued at
$202.1k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 6,000 options to buy
@ $0 |
|
| 07/14/2021 |
3
| Kamdar Kim P. (Director) has filed a Form 3 on SERA PROGNOSTICS, INC. |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Converted 4,395,633 shares
@ $0
Converted 2,666,781 options to buy
@ $0
Converted 1,293,243 convertible preferred
@ $0
Converted 435,609 convertible preferred
@ $0 |
|
| 05/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 27,250 options
@ $0
Granted 27,250 options to buy
@ $0.77, valued at
$21k
|
|
| 06/16/2020 |
4
| Kamdar Kim P. (10% Owner) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 5,000 shares
@ $2.94, valued at
$14.7k
|
|
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2019 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 12,500 shares
@ $4, valued at
$50k
Bought 9,375 options to buy
@ $4.4, valued at
$41.3k
|
|
| 07/25/2019 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 78,125 shares
@ $0 |
|
| 06/07/2019 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $6.05, valued at
$302.5k
|
|
| 05/23/2019 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 655 shares
@ $5.07, valued at
$3.3k
Acquired 4,287 shares
@ $0 |
|
| 08/27/2018 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 54,945 shares
@ $1.82, valued at
$100k
|
|
| 08/21/2018 |
3
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 06/15/2018 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 81,774 options to buy
@ $2.36, valued at
$193k
|
|
| 05/10/2018 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 12,875 options to buy
@ $6.99, valued at
$90k
|
|
| 12/13/2017 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 47,963 shares
@ $0 |
|
| 06/22/2017 |
4
| Kamdar Kim P. (10% Owner) has filed a Form 4 on Neothetics, Inc.|
Txns:
| Granted 12,450 options to buy
@ $2.19, valued at
$27.3k
|
|
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/15/2017 |
4
| Kamdar Kim P. (10% Owner) has filed a Form 4 on Neothetics, Inc. |
| 05/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 46,500 options to buy
@ $8.74, valued at
$406.4k
|
|
| 11/04/2016 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Unknown transaction of 38,094 shares
@ $28.35, valued at
$1.1M
Disposed/sold 1,996 options to buy
@ $36, valued at
$71.9k
Disposed/sold 1,071 options to buy
@ $42.93, valued at
$46k
Disposed/sold 17,695 options to buy
@ $8.19, valued at
$144.9k
|
|
| 11/02/2016 |
4
| Kamdar Kim P. (10% Owner) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 8,000 options to buy
@ $11.81, valued at
$94.5k
|
|
| 10/14/2016 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 13,400 shares
@ $15, valued at
$201k
|
|
|
|
|